AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2010
Dec 21, 2010
31542_dirs_2010-12-21_a011126a-e15d-45ae-94a5-004353813f59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Catalyst Pharmaceutical Partners, Inc. (CPRX)
CIK: 0001369568
Period of Report: 2010-12-20
Reporting Person: Weinstein Jack (V.P., Treasurer & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-20 | Common Stock, par value $0.001 per share | P | 2000 | $0.9489 | Acquired | 13993 | Direct |
| 2010-12-20 | Common Stock, par value $0.001 per share | P | 500 | $0.96 | Acquired | 14493 | Direct |
More from CATALYST PHARMACEUTICALS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jul 8
Proxy Solicitation & Information Statement
2026
Jun 30
Regulatory Filings
2026
Jun 30
Regulatory Filings
2026
Jun 23
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Call Transcript
2026
Mar 10
Call Transcript
2026
Feb 26